Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
interferon alpha-2b (Intron-A) (3 trials)
ribavirin (virazole) (2 trials)
Communicable Diseases (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 3)
Infections (Phase 3)
Virus Diseases (Phase 3)
Trials (3 total)
Trial APIs (2 total)